Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
CBFV vs MNSB vs CARE vs FUNC vs FXNC
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
CBFV vs MNSB vs CARE vs FUNC vs FXNC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $190M | $184M | $662M | $272M | $273M |
| Revenue (TTM) | $69M | $135M | $252M | $120M | $115M |
| Net Income (TTM) | $5M | $16M | $31M | $25M | $18M |
| Gross Margin | 62.5% | 54.3% | 61.2% | 70.3% | 74.7% |
| Operating Margin | 7.7% | 14.1% | 15.9% | 27.2% | 19.0% |
| Forward P/E | 12.6x | 11.0x | 5.5x | 9.7x | 12.8x |
| Total Debt | $35M | $70M | $179M | $115M | $43M |
| Cash & Equiv. | $32M | $26M | $105M | $132M | $161M |
CBFV vs MNSB vs CARE vs FUNC vs FXNC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| CB Financial Servic… (CBFV) | 100 | 171.9 | +71.9% |
| MainStreet Bancshar… (MNSB) | 100 | 188.9 | +88.9% |
| Carter Bankshares, … (CARE) | 100 | 370.2 | +270.2% |
| First United Corpor… (FUNC) | 100 | 313.9 | +213.9% |
| First National Corp… (FXNC) | 100 | 217.5 | +117.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CBFV vs MNSB vs CARE vs FUNC vs FXNC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CBFV has the current edge in this matchup, primarily because of its strength in income & stability and sleep-well-at-night.
- Dividend streak 1 yrs, beta 0.41, yield 2.6%
- Lower volatility, beta 0.41, Low D/E 22.1%, current ratio 0.02x
- Beta 0.41, yield 2.6%, current ratio 0.02x
- Beta 0.41 vs FUNC's 0.67, lower leverage
MNSB is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- Efficiency ratio 0.4% vs CBFV's 0.5% (lower = leaner)
- Efficiency ratio 0.4% vs CBFV's 0.5%
CARE ranks third and is worth considering specifically for value and momentum.
- Lower P/E (5.5x vs 12.8x)
- +79.6% vs CBFV's +34.6%
FUNC is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 361.3% 10Y total return vs CARE's 141.7%
- PEG 0.74 vs FXNC's 8.59
FXNC is the clearest fit if your priority is growth exposure and bank quality.
- Rev growth 27.1%, EPS growth 96.0%
- NIM 3.6% vs CARE's 2.7%
- 27.1% NII/revenue growth vs CBFV's -13.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 27.1% NII/revenue growth vs CBFV's -13.3% | |
| Value | Lower P/E (5.5x vs 12.8x) | |
| Quality / Margins | Efficiency ratio 0.4% vs CBFV's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.41 vs FUNC's 0.67, lower leverage | |
| Dividends | 2.6% yield, 1-year raise streak, vs FXNC's 2.0%, (1 stock pays no dividend) | |
| Momentum (1Y) | +79.6% vs CBFV's +34.6% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs CBFV's 0.5% |
CBFV vs MNSB vs CARE vs FUNC vs FXNC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CBFV vs MNSB vs CARE vs FUNC vs FXNC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
FUNC leads in 1 of 6 categories
CBFV leads 0 • MNSB leads 0 • CARE leads 0 • FXNC leads 0 • 5 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — FUNC and FXNC each lead in 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CARE is the larger business by revenue, generating $252M annually — 3.7x CBFV's $69M. FUNC is the more profitable business, keeping 20.5% of every revenue dollar as net income compared to CBFV's 7.1%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $69M | $135M | $252M | $120M | $115M |
| EBITDAEarnings before interest/tax | $7M | $23M | $46M | $35M | $25M |
| Net IncomeAfter-tax profit | $5M | $16M | $31M | $25M | $18M |
| Free Cash FlowCash after capex | $17M | $11M | $30M | $16M | $21M |
| Gross MarginGross profit ÷ Revenue | +62.5% | +54.3% | +61.2% | +70.3% | +74.7% |
| Operating MarginEBIT ÷ Revenue | +7.7% | +14.1% | +15.9% | +27.2% | +19.0% |
| Net MarginNet income ÷ Revenue | +7.1% | +11.5% | +12.5% | +20.5% | +15.4% |
| FCF MarginFCF ÷ Revenue | +24.8% | +7.9% | +11.9% | +13.1% | +18.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +93.5% | +120.9% | +8.3% | +20.2% | +7.1% |
Valuation Metrics
Evenly matched — MNSB and FUNC each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 11.1x trailing earnings, FUNC trades at a 73% valuation discount to CBFV's 40.8x P/E. Adjusting for growth (PEG ratio), FUNC offers better value at 0.85x vs FXNC's 10.32x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $190M | $184M | $662M | $272M | $273M |
| Enterprise ValueMkt cap + debt − cash | $193M | $227M | $735M | $255M | $155M |
| Trailing P/EPrice ÷ TTM EPS | 40.78x | 14.16x | 21.34x | 11.11x | 15.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.62x | 11.03x | 5.47x | 9.66x | 12.82x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.85x | 10.32x |
| EV / EBITDAEnterprise value multiple | 27.19x | 11.90x | 18.38x | 7.85x | 7.05x |
| Price / SalesMarket cap ÷ Revenue | 2.77x | 1.35x | 2.60x | 2.28x | 2.43x |
| Price / BookPrice ÷ Book value/share | 1.26x | 0.87x | 1.60x | 1.34x | 1.46x |
| Price / FCFMarket cap ÷ FCF | 11.09x | 17.26x | 20.81x | 17.67x | 12.99x |
Profitability & Efficiency
Evenly matched — FUNC and FXNC each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
FUNC delivers a 12.6% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $3 for CBFV. CBFV carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to FUNC's 0.56x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs MNSB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.2% | +7.3% | +7.6% | +12.6% | +10.0% |
| ROA (TTM)Return on assets | +0.3% | +0.7% | +0.7% | +1.2% | +0.9% |
| ROICReturn on invested capital | +2.1% | +5.0% | +5.7% | +7.1% | +7.7% |
| ROCEReturn on capital employed | +2.9% | +6.0% | +1.5% | +9.8% | +9.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 8 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.22x | 0.32x | 0.43x | 0.56x | 0.23x |
| Net DebtTotal debt minus cash | $3M | $43M | $73M | -$17M | -$118M |
| Cash & Equiv.Liquid assets | $32M | $26M | $105M | $132M | $161M |
| Total DebtShort + long-term debt | $35M | $70M | $179M | $115M | $43M |
| Interest CoverageEBIT ÷ Interest expense | 0.21x | 0.31x | 0.39x | 0.99x | 0.84x |
Total Returns (Dividends Reinvested)
FUNC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in FUNC five years ago would be worth $24,187 today (with dividends reinvested), compared to $11,813 for MNSB. Over the past 12 months, CARE leads with a +79.6% total return vs CBFV's +34.6%. The 3-year compound annual growth rate (CAGR) favors FUNC at 43.0% vs MNSB's 4.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +9.8% | +26.5% | +54.3% | +14.3% | +24.4% |
| 1-Year ReturnPast 12 months | +34.6% | +37.2% | +79.6% | +44.4% | +57.8% |
| 3-Year ReturnCumulative with dividends | +103.8% | +13.1% | +93.9% | +192.2% | +103.7% |
| 5-Year ReturnCumulative with dividends | +93.7% | +18.1% | +108.0% | +141.9% | +71.0% |
| 10-Year ReturnCumulative with dividends | +114.0% | +135.4% | +141.7% | +361.3% | +258.5% |
| CAGR (3Y)Annualised 3-year return | +26.8% | +4.2% | +24.7% | +43.0% | +26.8% |
Risk & Volatility
Evenly matched — CBFV and CARE each lead in 1 of 2 comparable metrics.
Risk & Volatility
CBFV is the less volatile stock with a 0.41 beta — it tends to amplify market swings less than FUNC's 0.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.41x | 0.60x | 0.58x | 0.67x | 0.52x |
| 52-Week HighHighest price in past year | $37.92 | $25.17 | $29.99 | $42.35 | $30.51 |
| 52-Week LowLowest price in past year | $27.11 | $17.86 | $16.14 | $28.00 | $18.31 |
| % of 52W HighCurrent price vs 52-week peak | +98.9% | +99.0% | +99.6% | +98.9% | +99.0% |
| RSI (14)Momentum oscillator 0–100 | 67.1 | 65.3 | 72.8 | 71.6 | 67.0 |
| Avg Volume (50D)Average daily shares traded | 4K | 45K | 316K | 13K | 79K |
Analyst Outlook
Evenly matched — CBFV and FXNC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CBFV as "Hold", MNSB as "Hold", CARE as "Hold", FUNC as "Buy", FXNC as "Buy". Consensus price targets imply -4.6% upside for CARE (target: $29) vs -40.3% for FUNC (target: $25). For income investors, CBFV offers the higher dividend yield at 2.58% vs MNSB's 1.60%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | — | $28.50 | $25.00 | $21.00 |
| # AnalystsCovering analysts | 3 | 1 | 5 | 1 | 1 |
| Dividend YieldAnnual dividend ÷ price | +2.6% | +1.6% | — | +2.2% | +2.0% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 0 | 7 | 11 |
| Dividend / ShareAnnual DPS | $0.97 | $0.40 | — | $0.92 | $0.61 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.6% | +2.4% | +3.0% | 0.0% | +0.1% |
FUNC leads in 1 of 6 categories — strongest in Total Returns. 5 categories are tied.
CBFV vs MNSB vs CARE vs FUNC vs FXNC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CBFV or MNSB or CARE or FUNC or FXNC a better buy right now?
For growth investors, First National Corporation (FXNC) is the stronger pick with 27.
1% revenue growth year-over-year, versus -13. 3% for CB Financial Services, Inc. (CBFV). First United Corporation (FUNC) offers the better valuation at 11. 1x trailing P/E (9. 7x forward), making it the more compelling value choice. Analysts rate First United Corporation (FUNC) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CBFV or MNSB or CARE or FUNC or FXNC?
On trailing P/E, First United Corporation (FUNC) is the cheapest at 11.
1x versus CB Financial Services, Inc. at 40. 8x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: First United Corporation wins at 0. 74x versus First National Corporation's 8. 59x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CBFV or MNSB or CARE or FUNC or FXNC?
Over the past 5 years, First United Corporation (FUNC) delivered a total return of +141.
9%, compared to +18. 1% for MainStreet Bancshares, Inc. (MNSB). Over 10 years, the gap is even starker: FUNC returned +361. 3% versus CBFV's +114. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CBFV or MNSB or CARE or FUNC or FXNC?
By beta (market sensitivity over 5 years), CB Financial Services, Inc.
(CBFV) is the lower-risk stock at 0. 41β versus First United Corporation's 0. 67β — meaning FUNC is approximately 61% more volatile than CBFV relative to the S&P 500. On balance sheet safety, CB Financial Services, Inc. (CBFV) carries a lower debt/equity ratio of 22% versus 56% for First United Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — CBFV or MNSB or CARE or FUNC or FXNC?
By revenue growth (latest reported year), First National Corporation (FXNC) is pulling ahead at 27.
1% versus -13. 3% for CB Financial Services, Inc. (CBFV). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to -61. 3% for CB Financial Services, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CBFV or MNSB or CARE or FUNC or FXNC?
First United Corporation (FUNC) is the more profitable company, earning 20.
6% net margin versus 7. 1% for CB Financial Services, Inc. — meaning it keeps 20. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FUNC leads at 27. 3% versus 7. 7% for CBFV. At the gross margin level — before operating expenses — FXNC leads at 74. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CBFV or MNSB or CARE or FUNC or FXNC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, First United Corporation (FUNC) is the more undervalued stock at a PEG of 0. 74x versus First National Corporation's 8. 59x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 5. 5x forward P/E versus 12. 8x for First National Corporation — 7. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CARE: -4. 6% to $28. 50.
08Which pays a better dividend — CBFV or MNSB or CARE or FUNC or FXNC?
In this comparison, CBFV (2.
6% yield), FUNC (2. 2% yield), FXNC (2. 0% yield), MNSB (1. 6% yield) pay a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.
09Is CBFV or MNSB or CARE or FUNC or FXNC better for a retirement portfolio?
For long-horizon retirement investors, First National Corporation (FXNC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
52), 2. 0% yield, +258. 5% 10Y return). Both have compounded well over 10 years (FXNC: +258. 5%, CARE: +141. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CBFV and MNSB and CARE and FUNC and FXNC?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CBFV is a small-cap quality compounder stock; MNSB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock; FUNC is a small-cap deep-value stock; FXNC is a small-cap high-growth stock. CBFV, MNSB, FUNC, FXNC pay a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.